| 沙利度胺联合CHOP方案治疗淋巴瘤24例的临床观察 |
| |
| 引用本文： | 詹扬,姚福生.沙利度胺联合CHOP方案治疗淋巴瘤24例的临床观察[J].安徽卫生职业技术学院学报,2013,12(2):33-33,62. |
| |
| 作者姓名： | 詹扬 姚福生 |
| |
| 作者单位： | 詹扬 (安庆市立医院血液科,安徽,246003)；姚福生 (安庆市立医院血液科,安徽,246003)； |
| |
| 摘 要： | 目的:观察沙利度胺在侵袭性非霍奇金淋巴瘤(NHL)中的治疗作用及不良反应。方法:24例侵袭性恶性淋巴瘤患者,临床分期按Ann Arbor国际分期,ⅡB期3例,ⅢA期9例,ⅢB期8例,ⅣA期2例,ⅣB期2例。结果:沙利度胺联合CHOP方案治疗NHL有效率为62.5%。结论:该方案适合临床使用,具有进一步临床观察的价值。
|
| 关 键 词： | 沙利度胺 淋巴瘤 分期 疗效 |
Clinical observation of 24 cases of lymphoma treated by thalidomide combined with CHOP regimen |
| |
| Anqing Municipal Hospital,Anqing,Anhui ZHAN Yang,YAO Fu-sheng.Clinical observation of 24 cases of lymphoma treated by thalidomide combined with CHOP regimen[J].Journal of Anhui Heaith Vocational & Technical College,2013,12(2):33-33,62. |
| |
| Authors: | Anqing Municipal Hospital Anqing Anhui ZHAN Yang YAO Fu-sheng |
| |
| Institution: | Anqing Municipal Hospital,Anqing 246003,Anhui ZHAN Yang, YAO Fu-sheng |
| |
| Abstract: | Objective ： To observe therapeutic effect and adverse reactions of thalidomide in the treatment of ag- gressive non-Hodgkin＇s lymphoma （NHL）.Method：According to the Ann Arbor staging, among 24 cases of invasive malignant lymphomapatients, 3 cases were in Ⅱ B clinical stage, 9 cases Ⅲ A, 8 cases in Ⅲ B,2 cases in Ⅳ A and Ⅳ B Result ：The clinical effective rate was 62.5% for treating N HL with tahlidomide combined with C HOP. Conclusion ：Thalidomide is suitable for clinical use for aggressive non-Hodgkin＇s lymphoma （NHL）, with further clinical observation value. |
| |
| Keywords: | Thalidomide lymphoma stage effectiveness |
| 本文献已被 CNKI 维普 等数据库收录！ |
|
